FindTrial
Sign In

To see the effect of khadirashtak kwath ghan vati in the treatment of vicharchika (skin disease)

Randomised controlled clinical trial to evaluate efficacy between â??Khadirashtak kwath ghanvatiâ?? with tab. Takzema in the management of â??Vicharchikaâ??. - RKTV

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036968
Enrollment
66
Registered
2021-09-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

Intervention1: Khadirashtak Kwath Ghanavati : Group A will be treated with Khadirashtak Kwath Ghanavati 500mg BD in vyanodane kaal with koshn jal in 18 to 60 year age group for 1 month which includes

Sponsors

PDEAs College of Ayurved and Research centre Nigdi Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with clinical features of Vicharchika having signs and symptoms namely Kandu(itching),Pidaka(Eruption),Vaivarnya(Depigmentation) and Srava (Discharge).

Exclusion criteria

Exclusion criteria: Patient having severe systemic diseases or condition along with Vicharchika and Pregnant & Lactating woman.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of khadirashtak kwath ghanvati 500mg BD in vyanodane kaal with koshn jal for 1 month and tab. Takzema 500 mg BD in vyanodane kaal with koshn jal in the manegment of vicharchika. Timepoint: One month with follow up on 15th and 30th day.—

Secondary

MeasureTime frame
To compare and study the efficacy of khadirashtak kwath ghan vati . To compare and study the efficacy of tab. Takzema To observe the adverse effects, if any.Timepoint: One month with follow up on 15th and 30th day.—

Countries

India

Contacts

Public ContactDr Rameshwar Vaijinath Jadhav

PDEAs College of Ayurved and Research centre ,Nigdi ,Pune

atramsurekha@gmail.com749893921

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026